Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Chronic Disease Sufferers To Benefit From New ‘At Home’ Diagnostic Device

22.07.2004


People who suffer from chronic diseases, including high blood pressure, diabetes, asthma and heart problems should benefit from a new remote, home care monitoring system that could also bring an end to overcrowded waiting rooms.



With project partners in Estonia, Latvia and the UK facing research costs of over €2 million, the development of Doc@HOME® was made possible with the help of a grant of €1.1 million from the Information Society Technology (IST) Programme of the European Union’s Framework Programme. It is now set to improve the quality of life of thousands of people, including the elderly and disabled, by freeing up time currently spent on doctors and hospital visits. This in turn will help ease the pressure on the family doctor.

Low cost and easy to use, Doc@HOME® gives the patient a sense of control over their condition and allows their medical carers to stay ahead of the disease. It also provides education about the disease and its risk factors, and supports lifestyle modification strategies that need to be introduced to help manage the condition.


Adrian Flowerday, managing director of the UK partner Docobo UK, is confident the new system will be welcomed around the world, saying: "The World Health Organisation sees Chronic Disease as being the greatest challenge to the healthcare systems and populations of the world this century. The Doc@HOME® service provides a low cost, home based chronic disease management solution to help the national healthcare organisations address these challenges. Patients with chronic diseases such as hypertension, Chronic Obstructive Pulmonary Disease (COPD) and diabetes will be enabled to monitor and control their own condition, confident in the knowledge that the healthcare systems are monitoring their progress."

Peter Walters, UK National Contact Point for IST within the EU’s 6th Framework Programme, believes that the Doc@HOME® project is a prime example of the major contribution EU funding has in the development of information and communications technology: “This project shows how, with the right financial support, information technology can have a much wider role to play in our futures. Without support from the EU’s Framework Programme this project may not have been possible.”

“The Framework Programmes are the EU’s main vehicle for support of leading edge, internationally collaborative R&D. The current Framework Programme (FP6) runs until 2006 and organisations wanting free information on how to access some of the €17.5bn available should log on to http://fp6uk.ost.gov.uk or call central telephone support on 0870 600 6080.”

With over two billion people in the world suffering with Hypertension and Diabetes, conservative forecasts indicate that Doc@HOME® will have around 300,000 users by 2007. Potential customers for the system include both public and private healthcare organisations, health conscious consumers, insurance companies and occupational health departments within large employers, and the manufacturers have already identified a potential sales revenue of £70 million.

The system is being trailed with two NHS organisations and patients involved in the trials are pleased with the service. “I would like to control my blood pressure without having to become dependant upon medication,” says businessman Ian MacDonald of Glasgow. “The Doc@HOME® service helped me to appreciate and control my blood pressure. I had to travel a lot during the period of the trial and this handy, portable unit made it easy to monitor my blood pressure and adjust my lifestyle accordingly. Anything that enables people to have better control of their health must be a good thing.”

Fellow patient John Millar, also from Glasgow, added: “It will be particularly helpful to people just starting on medication as it also reminds you when to take it. I would also recommend it to my doctor as I believe that any system that helps reduce the pressure on him has got to be a great concept.”

The device includes basic ECG capability for arrhythmia and the detection of other long terms trends. It can also integrate with other pieces of medical equipment – blood pressure, weight, glucose measuring devices etc - to collect, store and forward the entered data.

Already the system is being adapted for patients who need regular monitoring for a number of medical conditions, including: Chronic Heart Failure (CHF), Asthma, Diabetes, Post-Stroke care and surveillance, Chronic Obstructive Pulmonary Disease, Chronic respiratory disease.

The system is also expandable to more general interest groups like weight control and personal fitness programs, and reduces the overall cost of patient care, bringing a rage of benefits to the patient, their family and their doctor.

Patient benefits include:

A more active role in the health support process.
More control over the symptoms of illness and therefore more freedom of life.
Improved chances to continue regular working by freeing up the time spent on regular visits to medical institutions.
The sense of care immediacy.

Benefits to the doctor include:

A continuous and adequate overview of the health status of the patient in their actual living environment.
Easier management of a large number of patients.
A reduction of the misplaced time and expenditures.

Family members also benefit by having a better overview of the health status of their relative, and the pressure on hospitals will be eased thanks to a reduction of admissions of patients with chronic conditions for routine examination.

The system is built around a low-cost device (the projected end user cost is around 200 Euros) specially constructed for the purpose of long-term trouble free data collection, with design features considering the needs of the typical home care population (elderly people, disabled people etc).

Dave Sanders | alfa
Further information:
http://www.glasgows.co.uk

More articles from Health and Medicine:

nachricht Nitric oxide-scavenging hydrogel developed for rheumatoid arthritis treatment
06.06.2019 | Pohang University of Science & Technology (POSTECH)

nachricht Infants later diagnosed with autism follow adults’ gaze, but seldom initiate joint attention
24.05.2019 | Schwedischer Forschungsrat - The Swedish Research Council

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The hidden structure of the periodic system

The well-known representation of chemical elements is just one example of how objects can be arranged and classified

The periodic table of elements that most chemistry books depict is only one special case. This tabular overview of the chemical elements, which goes back to...

Im Focus: MPSD team discovers light-induced ferroelectricity in strontium titanate

Light can be used not only to measure materials’ properties, but also to change them. Especially interesting are those cases in which the function of a material can be modified, such as its ability to conduct electricity or to store information in its magnetic state. A team led by Andrea Cavalleri from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg used terahertz frequency light pulses to transform a non-ferroelectric material into a ferroelectric one.

Ferroelectricity is a state in which the constituent lattice “looks” in one specific direction, forming a macroscopic electrical polarisation. The ability to...

Im Focus: Determining the Earth’s gravity field more accurately than ever before

Researchers at TU Graz calculate the most accurate gravity field determination of the Earth using 1.16 billion satellite measurements. This yields valuable knowledge for climate research.

The Earth’s gravity fluctuates from place to place. Geodesists use this phenomenon to observe geodynamic and climatological processes. Using...

Im Focus: Tube anemone has the largest animal mitochondrial genome ever sequenced

Discovery by Brazilian and US researchers could change the classification of two species, which appear more akin to jellyfish than was thought.

The tube anemone Isarachnanthus nocturnus is only 15 cm long but has the largest mitochondrial genome of any animal sequenced to date, with 80,923 base pairs....

Im Focus: Tiny light box opens new doors into the nanoworld

Researchers at Chalmers University of Technology, Sweden, have discovered a completely new way of capturing, amplifying and linking light to matter at the nanolevel. Using a tiny box, built from stacked atomically thin material, they have succeeded in creating a type of feedback loop in which light and matter become one. The discovery, which was recently published in Nature Nanotechnology, opens up new possibilities in the world of nanophotonics.

Photonics is concerned with various means of using light. Fibre-optic communication is an example of photonics, as is the technology behind photodetectors and...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

 
Latest News

Uncovering hidden protein structures

18.06.2019 | Life Sciences

Monitoring biodiversity with sound: how machines can enrich our knowledge

18.06.2019 | Life Sciences

Schizophrenia: Adolescence is the game-changer

18.06.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>